ONE NUCLEUS STRENGTHENS BOARD WITH APPOINTMENT OF NEW DIRECTOR

Life Sciences industry leader joins the region’s Life Science & Healthcare membership organisation
Cambridge, UK: 10 April 2024

Life Sciences industry leader joins the region’s Life Science & Healthcare membership organisation
Cambridge, UK: 10 April 2024
Drug development consultancy Boyds has appointed Kate Owen as Medical Director in its Clinical and Medical Affairs team.
Prime.io - a london based cell line engineering service CRO company appoints Sir Tony Kouzarides to support long-term strategy for its Next Generation Cell Line Engineering Services.
Tony is a highly cited academic and entrepreneur who co-founded both the Milner Therapeutics Institute and Abcam (NASDAQ: ABCM). As scientific advisor, he will help guide prime.io's scientific strategy and explore new opportunities to raise awareness of the Company’s mission to edit genes and accelerate drug discovery.
Discover Veranova:
At Veranova, we believe people are our most important asset, and we are dedicated to building the most talented and diverse workforce in our industry. Our commitment to uncompromising focus on quality, compliance, safety, and excellence in delivery shapes everything we do. We are not just looking for skills; we are seeking innovative individuals who have a mindset open to learning and growth, and a desire to make a difference.
Company Description
Thought-provoking discussions with leaders on Next-Gen Therapies, how to prepare to get funding and how AI is changing clinical trials.
Do you want to help us improve human health and understand life on Earth? Make your mark by shaping the future to enable or deliver life-changing science to solve some of humanity’s greatest challenges.
BIO is the world’s largest advocacy association representing biotechnology companies, academic and research institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations.
The UK Pavilion will be organised by the Office for Life Sciences (OLS). Pavilion exhibitors are granted access to the partnering system, with limited location access. It is recommended that one delegate uses the exhibitor partnering access, and a second delegate purchases a Premier pass here.
Since 2021, the Swiss Biotech Day has seen remarkable growth and has become a premier global biotechnology conference for life sciences professionals, fostering international collaboration and impactful partnerships. In 2025 it attracted more than 3,000 participants from 49 countries, including 25 international delegations.
*One Nucleus members receive a 12% discount via BioPartner, please email [email protected] for more information.